Trevi therapeutics inc. ir
WebJun 9, 2024 · NEW HAVEN, Conn., June 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development … WebApr 11, 2024 · Fireside chat will be held on Monday, April 17, 2024, at 11:00 a.m. ET NEW HAVEN, Conn., April 11, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical ...
Trevi therapeutics inc. ir
Did you know?
WebApr 11, 2024 · Trevi Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference Fireside chat will be held on Monday, April 17, 2024, at 11:00 a.m. … Katie McManus (203) 903-9627 [email protected]. Trevi Therap… WebMar 27, 2024 · Trevi Therapeutics Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.360 per share for the current fiscal year. Trevi Therapeutics Inc does not currently pay a dividend. The Biotechnology and Medical Research sub ...
WebApr 11, 2024 · Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing Haduvio, an investigational therapy in an oral extended-release formulation of nalbuphine, for the treatment of ... WebApr 11, 2024 · Fireside chat will be held on Monday, April 17, 2024, at 11:00 a.m. ET NEW HAVEN, Conn., April 11, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a …
WebAug 11, 2024 · NEW HAVEN, Conn., Aug. 11, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing an investigational … WebMay 13, 2024 · Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy …
WebApr 6, 2024 · As of April 6, 2024, the average one-year price target for Trevi Therapeutics is $7.75. The forecasts range from a low of $6.06 to a high of $9.45. The average price target represents an increase ...
WebApr 11, 2024 · Trevi intends to propose Haduvio as the trade name for nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority. For more … fire hydrant accessoriesWebApr 11, 2024 · Trevi intends to propose Haduvio as the trade name for nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority. For more information, visit www.TreviTherapeutics.com and follow the Company on Twitter and LinkedIn. Investor Contact Katie McManus Trevi Therapeutics, Inc. 203-304-2499 … fire hydrant 4WebMay 7, 2024 · NEW HAVEN, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ... ethery inasaridse